Assignee
PROGENICS PHARM INC
US·63 granted patents·31 pending applications·1,216 citations·filing 1993–2024
Top patents by PatentIndex Score
94 records- 0199US12224067B1Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2024·Granted Feb 11, 2025·7 cites·34 claims
- 0299US11894141B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2022·Granted Feb 6, 2024·11 cites·35 claims
- 0399US11424035B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2020·Granted Aug 23, 2022·18 cites·45 claims
- 0499US10762993B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2019·Granted Sep 1, 2020·25 cites·21 claims
- 0598US12431246B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2023·Granted Sep 30, 2025·2 cites·36 claims
- 0697US11544407B1Systems and methods for secure cloud-based medical image upload and processingPROGENICS PHARM INC·Filed 2020·Granted Jan 3, 2023·10 cites·23 claims
- 0797US10665346B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2019·Granted May 26, 2020·25 cites·13 claims
- 0897US10340046B2Network for medical image analysis, decision support system, and related graphical user interface (GUI) applicationsPROGENICS PHARM INC·Filed 2017·Granted Jul 2, 2019·32 cites·21 claims
- 0996US11937962B2Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesPROGENICS PHARM INC·Filed 2022·Granted Mar 26, 2024·11 cites·30 claims
- 1096US11564621B2Systems and methods for artificial intelligence-based image analysis for cancer assessmentPROGENICS PHARM INC·Filed 2020·Granted Jan 31, 2023·19 cites·21 claims
- 1196US11534125B2Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesPROGENICS PHARM INC·Filed 2020·Granted Dec 27, 2022·15 cites·34 claims
- 1295US11900597B2Systems and methods for artificial intelligence-based image analysis for cancer assessmentPROGENICS PHARM INC·Filed 2020·Granted Feb 13, 2024·12 cites·34 claims
- 1395US7592014B2Stabilized viral envelope proteins and uses thereofPROGENICS PHARM INC·Filed 2005·Granted Sep 22, 2009·34 cites·17 claims
- 1495US7345153B2Compounds capable of inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2006·Granted Mar 18, 2008·23 cites·7 claims
- 1594US12414748B2Systems and methods for automated and interactive analysis of bone scan images for detection of metastasesPROGENICS PHARM INC·Filed 2024·Granted Sep 16, 2025·3 cites·24 claims
- 1694US12417533B2Systems and methods for artificial intelligence-based image analysis for cancer assessmentPROGENICS PHARM INC·Filed 2023·Granted Sep 16, 2025·4 cites·20 claims
- 1794US10973486B2Systems and methods for rapid neural network-based image segmentation and radiopharmaceutical uptake determinationPROGENICS PHARM INC·Filed 2018·Granted Apr 13, 2021·41 cites·55 claims
- 1894US7674904B2Synthesis of R-N-methylnaltrexonePROGENICS PHARM INC·Filed 2006·Granted Mar 9, 2010·52 cites·24 claims
- 1994US7060273B2Methods for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2002·Granted Jun 13, 2006·32 cites·24 claims
- 2094US6692745B2Compositions and methods for inhibition of HIV-1 infectionPROGENICS PHARM INC·Filed 2000·Granted Feb 17, 2004·37 cites·15 claims
- 2193US7939083B2Soluble, stabilized, proteolytically cleaved, trimeric HIV-1 gp140 proteins comprising modifications in the N-terminus of the gp41 ectodomainPROGENICS PHARM INC·Filed 2007·Granted May 10, 2011·55 cites·21 claims
- 2293US6710173B1Stabilized viral envelope proteins and uses thereofPROGENICS PHARM INC·Filed 2000·Granted Mar 23, 2004·36 cites·30 claims
- 2392US7666419B2Anti-CCR5 antibodyPROGENICS PHARM INC·Filed 2006·Granted Feb 23, 2010·14 cites·36 claims
- 2492US7563899B2(S)-N-methylnaltrexonePROGENICS PHARM INC·Filed 2006·Granted Jul 21, 2009·36 cites·19 claims
- 2592US6548636B2Sulfated CCR5 peptides for HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Apr 15, 2003·54 cites·4 claims
- 2692US6344545B1Method for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Feb 5, 2002·91 cites·6 claims
- 2791US7118859B2Methods for inhibiting HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Oct 10, 2006·30 cites·8 claims
- 2891US7022324B2Stabilized viral envelope proteins and uses thereofPROGENICS PHARM INC·Filed 2001·Granted Apr 4, 2006·31 cites·20 claims
- 2990US8343992B2Synthesis of R-N-methylnaltrexonePROGENICS PHARM INC·Filed 2010·Granted Jan 1, 2013·14 cites·32 claims
- 3090US7138119B2Compositions and methods for inhibition of HIV-1 infectionPROGENICS PHARM INC·Filed 2001·Granted Nov 21, 2006·24 cites·15 claims
- 3189US6034223ANon-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 1995·Granted Mar 7, 2000·69 cites·8 claims
- 3287US5817767ASynergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using samePROGENICS PHARM INC·Filed 1993·Granted Oct 6, 1998·73 cites·6 claims
- 3386US9669096B2Stable pharmaceutical formulations of methylnaltrexonePROGENICS PHARM INC·Filed 2013·Granted Jun 6, 2017·5 cites·39 claims
- 3486US9597327B2Synthesis of (R)-N-methylnaltrexonePROGENICS PHARM INC·Filed 2015·Granted Mar 21, 2017·5 cites·26 claims
- 3586US6261763B1Fluorescence resonance energy transfer screening assay for the identification of compounds that are capable of abrogating macrophage-tropic HIV-1 cell fusionPROGENICS PHARM INC·Filed 1996·Granted Jul 17, 2001·38 cites·9 claims
- 3686US6107019AMethod for preventing HIV-1 infection of CD4+ cellsPROGENICS PHARM INC·Filed 1997·Granted Aug 22, 2000·78 cites·12 claims
- 3783US10376584B2Stable pharmaceutical formulations of methylnaltrexonePROGENICS PHARM INC·Filed 2017·Granted Aug 13, 2019·2 cites·15 claims
- 3883US7851600B2Anti-CCR5 antibodyPROGENICS PHARM INC·Filed 2006·Granted Dec 14, 2010·3 cites·27 claims
- 3982US7736649B2Methods of inhibiting human immunodeficiency virus infection through the administration of synergistic combinations of anti-CCR5 monoclonal antibodies, fusion inhibitors, and CD4-GP120 binding inhibitorsPROGENICS PHARM INC·Filed 2006·Granted Jun 15, 2010·1 cites·23 claims
- 4081US9102680B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2012·Granted Aug 11, 2015·4 cites·14 claims
- 4180US8003794B2(S)-N-methylnaltrexonePROGENICS PHARM INC·Filed 2009·Granted Aug 23, 2011·4 cites·12 claims
- 4279US7479553B2Nucleic acids encoding mutant disulfide bond-stabilized human immunodeficiency virus type 1 (HIV-1) gp140 envelope glycoproteinsPROGENICS PHARM INC·Filed 2004·Granted Jan 20, 2009·4 cites·52 claims
- 4378US7022323B2Uses of DC-SIGN and DC-SIGNR for inhibiting hepatitis C virus infectionPROGENICS PHARM INC·Filed 2002·Granted Apr 4, 2006·3 cites·23 claims
- 4477US7935797B2CCR5 chemokine receptor-specific monoclonal antibodies capable of inhibiting HIV-1 cell fusionPROGENICS PHARM INC·Filed 2007·Granted May 3, 2011·1 cites·1 claims
- 4577US6972126B2Methods for using resonance energy transfer-based assay of HIV-1 envelope glycoprotein-mediated membrane fusion, and kits for practicing samePROGENICS PHARM INC·Filed 1999·Granted Dec 6, 2005·33 cites·3 claims
- 4676US6737267B2Non-peptidyl moiety-conjugated CD4-gamma2 and CD4-IgG2 immunoconjugates, and uses thereofPROGENICS PHARM INC·Filed 2001·Granted May 18, 2004·3 cites·48 claims
- 4773US12032722B2Systems and methods for secure cloud-based medical image upload and processingPROGENICS PHARM INC·Filed 2022·Granted Jul 9, 2024·0 cites·22 claims
- 4873US8916706B2Preparation and use of (R),(R)-2,2′-bis-methylnaltrexonePROGENICS PHARM INC·Filed 2013·Granted Dec 23, 2014·2 cites·30 claims
- 4972US9879024B2Crystal forms of (R)-N-methylnaltrexone bromide and uses thereofPROGENICS PHARM INC·Filed 2015·Granted Jan 30, 2018·1 cites·30 claims
- 5070US2007274986A1Compositions comprising anti-CCR5 antibodyPROGENICS PHARM INC·Filed 2007·Application pending·0 cites
Showing the top 50 of 94 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when PROGENICS PHARM INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →